Literature DB >> 30024979

Bi-frontal pneumocephalus is an independent risk factor for early postoperative agitation in adult patients admitted to intensive care unit after elective craniotomy for brain tumor: A prospective cohort study.

Hua-Wei Huang1, Li-Mei Yan1,2, Yan-Lin Yang1, Xuan He1, Xiu-Mei Sun1, Yu-Mei Wang1, Guo-Bin Zhang3, Jian-Xin Zhou1.   

Abstract

Postoperative agitation frequently occurs after general anesthesia and may be associated with serious consequences. However, studies in neurosurgical patients have been inadequate. We aimed to investigate the incidence and risk factors for early postoperative agitation in patients after craniotomy, specifically focusing on the association between postoperative pneumocephalus and agitation. Adult intensive care unit admitted patients after elective craniotomy under general anesthesia were consecutively enrolled. Patients were assessed using the Sedation-Agitation Scale during the first 24 hours after operation. The patients were divided into two groups based on their maximal Sedation-Agitation Scale: the agitation (Sedation-Agitation Scale ≥ 5) and non-agitation groups (Sedation-Agitation Scale ≤ 4). Preoperative baseline data, intraoperative and intensive care unit admission data were recorded and analyzed. Each patient's computed tomography scan obtained within six hours after operation was retrospectively reviewed. Modified Rankin Scale and hospital length of stay after the surgery were also collected. Of the 400 enrolled patients, agitation occurred in 13.0% (95% confidential interval: 9.7-16.3%). Body mass index, total intravenous anesthesia, intraoperative fluid intake, intraoperative bleeding and transfusion, consciousness after operation, endotracheal intubation kept at intensive care unit admission and mechanical ventilation, hyperglycemia without a history of diabetes, self-reported pain and postoperative bi-frontal pneumocephalus were used to build a multivariable model. Bi-frontal pneumocephalus and delayed extubation after the operation were identified as independent risk factors for postoperative agitation. After adjustment for confounding, postoperative agitation was independently associated with worse neurologic outcome (odd ratio: 5.4, 95% confidential interval: 1.1-28.9, P = 0.048). Our results showed that early postoperative agitation was prevalent among post-craniotomy patients and was associated with adverse outcomes. Improvements in clinical strategies relevant to bi-frontal pneumocephalus should be considered. TRIAL REGISTRATION: ClinicalTrials.gov (NCT02318199).

Entities:  

Mesh:

Year:  2018        PMID: 30024979      PMCID: PMC6053234          DOI: 10.1371/journal.pone.0201064

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Postoperative agitation after general anesthesia has been reported to occur in 3.7 to 29% of patients and may be associated with serious consequences, such as unplanned extubation, injuries and longer post-anesthesia care unit stay [1-7]. During the early stage of anesthesia recovery, neurosurgical patients may be more vulnerable to stress caused by agitation [8, 9]. Physiological fluctuations may result in edema, hemorrhage, and, ultimately, ischemia [10]. In our previous pilot study, which included 123 patients who underwent elective intracranial operations, we found the incidence of agitation within 12 hours postoperatively to be 29%, which was higher than that previously observed in other surgical populations [4]. However, investigations of this phenomenon in neurosurgical populations have been inadequate [1, 3, 5–7]. The most commonly reported independent risk factors for postoperative agitation in non-neurosurgical patients, including longer anesthesia duration, delayed extubation and pain, have also been found to present in neurosurgical patients [4, 8, 9]. However, brain lesions and intracranial manipulations in neurosurgical patients might affect the brain regions which involves cognition and emotion, and are assumed to influence postoperative cognition [4]. Moreover, during our clinical work, we noticed that post-craniotomy frontal pneumocephalus might also serve as a potential risk factor. Due to the preventable nature of pneumocephalus, further investigation is needed to clarify its relationship with agitation. Therefore, we conducted this prospective cohort study of adult patients who had undergone elective craniotomy for brain tumors. Incidence and clinical consequences of early postoperative agitation were documented. We aimed to investigate the risk factors for agitation, specifically focusing on the association between postoperative pneumocephalus and agitation. The association of agitation with long-term outcomes was also analyzed.

Materials and methods

Study design, ethics and patient population

This prospective cohort study was approved by the Institutional Review Board of Beijing Tiantan Hospital, Beijing, China (KY2014-034-01). Written informed consents were obtained from study subjects or their pre-defined healthcare decision makers. The study protocol was registered at ClinicalTrials.gov (NCT02318199; https://clinicaltrials.gov/ct2/show/NCT02318199). Three authors (HWH, LMY and JXZ) had access to information that could identify individual participants during and after data collection. The study was conducted in a neurosurgical ICU of a University affiliated hospital (Beijing, China) between Jan 1 and Aug 31, 2015. Patients admitted to the ICU after intracranial operations under general anesthesia were consecutively screened for study eligibility. The inclusion criterion was adult patients who had undergone elective craniotomy for brain tumors. The exclusion criteria included: 1) aged under 18 or over 80 years; 2) preoperative impairment of consciousness; 3) not following simple commands (lift hands or open mouth) during the first 24 hours after the operation; and 4) interval longer than 24 hours between the end of the operation and ICU admission.

Routine practices of neurosurgery, anesthesia and postoperative care

During the study, no attempts were made to change the standard of care, and routine practices were followed. In our institute, all neurosurgeons had to undergo standard pre-job training for intracranial operation, which included the instruction of adequate air removal via physical saline injection prior to dural closure. All intracranial surgeries were performed under general balanced anesthesia or total intravenous anesthesia (TIVA). Anesthesia was induced with intravenous propofol and sufentanil or remifentanil. Tracheal intubation was facilitated with intravenous rocuronium or cisatracurium. Anesthesia was maintained with propofol and/or sevoflurane or isoflurane. Sufentanil or remifentanil was administered intermittently or continuously, as needed. Muscle relaxant was administered according to train-of-four monitoring. The choice of agents was at the discretion of the anesthesiologist. For adult patients with brain tumors scheduled elective operation, the anesthesiologist and the neurosurgeon discussed postoperative ICU admission using criteria including, but were not limited to, age over 65 years, American Society of Anesthesiology (ASA) classification III or higher, large tumor or located at the brain stem, preoperative midline shift, preoperative consciousness impairment, anticipated prolonged operation and anticipated delayed extubation. At the end of the operation, the anesthesiologist and the neurosurgeon also discussed whether the patient had reasons for unplanned ICU admission, mainly including unanticipated delayed extubation, major intraoperative bleeding or brain swelling, injury to cranial nerve IX, X and XII, and severe cardiorespiratory instability during the attempt of emergence. Approximately half of the patients who had undergone elective craniotomy were admitted to the ICU for overnight postoperative monitoring. In the ICU, nurses evaluated the patientsGlasgow Coma Scale (GCS) scores and focal signs and performed pupillary examinations hourly or as needed. Most patients received patient-controlled intravenous analgesia (PCIA), which was composed of sufentanil 100 μg and tropisetron 10 mg in 100 ml 0.9% sodium chloride solution. A basal PCIA infusion (2 ml/h) is started after the confirmation of the patient’s cardiorespiratory stability and recovery of consciousness. A computed tomography (CT) scan was routinely performed within six hours postoperatively. All extubated patients received supplemental oxygen by simple face mask at flow of 3–6 L/min. In patients with delay extubation, oxygen was delivered by T tube. Mechanical ventilation was initiated when the patient could not maintain adequate spontaneous breathing or the pulse oxygenation saturation (SpO2) below 90%. Dexmedetomidine was continuously infused (0.4 μg/kg/h) in mechanically ventilated patients until they were weaned off the ventilator [10]. The presence of agitation and depth of sedation were evaluated using the Sedation-Agitation Scale (SAS) [11], which had been incorporated into clinical practice at our facility for more than three years [4]. All ICU physicians and nurses were trained to perform SAS assessment. Both nurses and physicians carefully evaluated patients with agitation (SAS score from 5 to 7) and excluded the possibility of organic causes of agitation, including pain, acute deterioration of cardiorespiratory function, a new neurologic event and hypoglycemia. When patients complained of pain, an intravenous bolus of fentanyl (25 μg) was administered. An intermittent or continuous intravenous infusion of midazolam was used for agitated patients, and the level of sedation was titrated until a SAS score of 3 to 4 was achieved. In patients with delayed extubation, after recovery from anesthesia, the ICU physician evaluated the patient’s reliability for extubation by a screening checklist, including assessments of consciousness, cardiorespiratory status, muscle strength recovery, gag reflex and cough function [12]. When each item in the checklist was passed, endotracheal extubation was performed by registered ICU nurses. Most patients were discharged from the ICU in the next morning after achieving normal neurological, hemodynamic and respiratory statuses.

Agitation assessment and definition

During the study period, four trained investigators took turns screening and evaluating the SAS scores of the patients. The SAS score of each eligible patient was evaluated hourly until the patient was capable of following commands (SAS ≥ 3). After enrolment, SAS scores were assessed every four hours or as needed until either 24 hours of evaluation or ICU discharge, whichever occurred first. Agitation was defined as a SAS score ranging from 5 to 7 [11]. The patients were divided into two groups based on their maximal SAS score: the agitation group (maximal SAS ≥ 5) and the non-agitation group (maximal SAS ≤ 4).

Assessment of postoperative CT scans

Two attending neuroradiologists who were blinded to agitation status retrospectively reviewed each patient’s first postoperative CT scans. Bi-frontal subdural pneumocephalus was defined by the following criteria: 1) subdural areas of hypoattenuation presenting bilaterally in the frontal region; 2) low attenuation mass presence in at least four serial axial slices (1 cm thickness); and 3) maximal displacement of the frontal lobe from the dura of more than 1 cm in at least one slice () [13, 14]. A special type of bi-frontal pneumocephalus, the “Mount Fuji sign”, was characterized by bilateral subdural hypoattenuating collections, collapsed frontal lobes and widening of the interhemispheric space between the tips of the frontal lobes () [15]. The “Mount Fuji sign” was deliberately inspected. Postoperative hematomas, ischemia and midline shifts were also observed. Two neuroradiologists independently reviewed the CT scans. Discrepancies were resolved by discussion until consensus was reached. Example CT scans identified as bi-frontal pneumocephalus (A) and “Mount Fuji sign” (B). Patients name and medical record number are masked. Bi-frontal pneumocephalus (A) was defined as complying with all three: 1) subdural areas of hypoattenuation were bilaterally presented in frontal region; 2) low attenuation mass existed in at least four serial axial slices (1 cm thickness); and 3) the maximal displacement of the frontal lobe from the dura was more than 1 cm at least in one slice. “Mount Fuji sign” (B) was identified by bilateral subdural hypoattenuating collections, collapsed frontal lobes and widening of the interhemispheric space between the tips of the frontal lobes.

Data collection

During the study period, the numbers of elective craniotomies performed for brain tumors and patients transferred to the ICU and neurosurgical ward were documented. The time of ICU admission and time interval between admission and enrolment were also recorded. Baseline and preoperative data were extracted from hospital records, including the patients’ demographic characteristics, ASA classification, health history (comorbid diseases, smoking and alcohol abuse, and long-term use of antidepressant drugs or benzodiazepines). The type of tumor (glioma or non-glioma) was documented based on the postoperative pathological reports issued during the follow-up period. Intraoperative data were extracted from anesthesia and operation records, including tumor location (supratentorial or infratentorial), surgical approach (frontal or non-frontal), anesthesia duration and method (balanced anesthesia or TIVA), fluid balance, bleeding amount, transfusion occurrence, mannitol and steroid use, and hypotension episode occurrence. ICU admission data were extracted from nursing records, including GCS (especially scores on the motor response subscale), body temperature, endotracheal tube kept at ICU admission and need for mechanical ventilation, central venous catheterization, external ventricular drainage tube and PCIA device placement, SpO2 below 90% and serum glucose concentration above 10 mmol/L (especially in patients without a history of diabetes). Complaints of pain during screening period before the enrollment were also documented. Patients were followed up until hospital discharge, death or 90 days after enrolment, whichever occurred first. Following data were collected from ICU nursing and hospital records, including self-extubation and accidental removal of catheter in the ICU, duration of mechanical ventilation, time of endotracheal extubation, occurrence of reintubation and tracheotomy, unexpected reoperation within 72 hours of surgery, and use of sedatives and fentanyl during ICU stay. Long-term outcomes, including hospital LOS after the surgery and modified Rankin Scale (mRS) scores, were collected at the end of follow-up. Poor neurologic outcome was defined as a mRS score of 5 or 6 [16]. Results of the retrospective analyses of the first postoperative CT scans were documented.

Statistical analysis

Categorical variables are expressed as counts (percentages), and continuous data are reported as medians with interquartile ranges (IQRs). Missing data and loss to follow-up were documented. The incidence of post-operative agitation and 95% confidential interval (CI) were calculated. The agitation and non-agitation groups were univariably compared to screen for potential confounding variables in a multivariable model predicting agitation. The associations of preoperative baseline variables, intraoperative variables, ICU admission data and CT scan data with the agitation were assessed. Categorical variables were compared using two-tailed Pearson chi-square tests, and Fisher’s exact tests were performed for variables with small cell counts. Continuous variables were compared using the Mann-Whitney U test. The possible interaction between variables was analyzed. Factors with P values < 0.05 in the univariable analysis were entered into the multivariable analysis with stepwise backward logistic regression to identify independent risk factors for agitation. Odds ratios (ORs) and 95% CIs were used to assess the independent contributions of significant factors. The Hosmer-Lemeshow test was used to determine whether the model fitted the data adequately well. The association of agitation with hospital LOS after the surgery and poor neurologic outcome was analyzed using a multivariable logistic regression analysis by confounding adjustment. Statistical analyses were performed using SPSS 20.0 (SPSS Inc., Chicago, IL, USA). A P value of less than 0.05 was considered statistically significant. According to standard recommendations, 10 cases of interest (agitation) would be required for each degree of freedom in the multivariable model to reliably fit the model. Therefore, a model with 4 degrees of freedom would require at least 40 patients with postoperative agitation [4]. We anticipated an average incidence of agitation in the present cohort using data from previous reports (11%) [1-7], and planned to enroll 400 cases to identify risk factors for postoperative agitation.

Results

During the study period, 1281 patients underwent elective craniotomy for brain tumors, of whom 784 returned to the neurosurgical ward and 497 were admitted to the ICU. After excluding 97 patients, 400 patients were included (). All patients were enrolled within six hours of ICU admission, with 258/400 (64.5%) patients enrolled just after admission, 131/400 (32.8%) patients enrolled between one and three hours after admission and 11/400 (2.7%) patients enrolled between four and six hours after admission. Three hundred sixty-one patients (361/400, 90.3%) were discharged on postoperative day 1, and the remaining patients (39/400, 9.7%) stayed in the ICU for longer than 24 hours.

The patients flow diagram.

Abbreviations: ICU, intensive care unit; SAS, Sedation-Agitation Scale.

Incidence of postoperative agitation

A total of 2019 SAS assessments were performed, with an average of five assessments per patient. SAS scores were ≥ 5 on 89/2019 (4.4%, 95% CI: 3.5–5.3%) of these assessments. According to the individual data, 300/400 (75.0%), 48/400 (12.0%), 21/400 (5.3%), 24/400 (6.0%) and 7/400 (1.8%) patients had a maximal SAS score of 3, 4, 5, 6 and 7, respectively. Thus, at least one episode of agitation (SAS ≥ 5) occurred in 52/400 (13.0%, 95% CI: 9.7–16.3%) patients.

Risk factors for postoperative agitation

In the univariable analyses, compared with the non-agitation group, patients in the agitation group had significantly higher body height and weight, intraoperative fluid intake, and amount of bleeding (and hourly bleeding); a significantly lower GCS score at ICU admission; and significantly more use of balanced anesthesia and higher occurrence of transfusion, endotracheal tube kept at ICU admission, need for mechanical ventilation, serum glucose concentration ≥ 10 mmol/L in patients without a history of diabetes, complaint of pain during screening, and bi-frontal pneumocephalus (Tables ). The “Mount Fuji sign” was identified in four cases (4/400, 1.0%), all in the non-agitation group and responsive to conservative therapy without operation. Bi-frontal pneumocephalus occurred more frequently in patients who underwent frontal approach than non-frontal approach operations (57/159 [35.8%] versus 33/241 [13.7%], P < 0.001), and in patients who underwent surgery for supratentorial tumors than for infratentorial tumors (58/209 [27.8%] versus 32/191 [16.8%], P = 0.009). Abbreviations: ADD, antidepressant drugs; ASA, American Society of Anesthesiologist; BMI, body mass index; CAD, coronary artery disease; ICU, intensive care unit; IQR, interquartile range. Abbreviations: IQR, interquartile range; TIVA, total intravenous anesthesia. Abbreviations: CT, computed tomography; CVC, central venous catheter; EVD, external ventricular drainage; GCS, Glasgow Coma Scale; ICU, intensive care unit; IQR, interquartile range; PCIA, patient-controlled intravenous analgesia; SpO2, pulse oxygenation saturation. In the multivariable analyses, we combined body height and weight as body mass index (, P = 0.064). We included the hourly amount of bleeding variable (, P = 0.018) to avoid the influence of the anesthesia duration variable. To clarify the interaction between bleeding and transfusion, we arbitrarily stratified patients into two clusters according to the median of the hourly bleeding variable (71 ml/h) as having major (> 71 ml/h) and minor intraoperative bleeding (≤ 71 ml/h). We then divided the patients into three classifications: 1) minor bleeding; 2) major bleeding without transfusion; and 3) major bleeding with transfusion (). By combining the endotracheal tube and mechanical ventilation variables, we categorized patients into the following groups: 1) extubated in the operating room; 2) endotracheal tube kept at ICU admission without the need for mechanical ventilation; and 3) endotracheal tube kept at ICU admission with the need for mechanical ventilation (). The classification of the intraoperative bleeding and transfusion as well as endotracheal tube and mechanical ventilation variables were included as a categorical covariate in the multivariable models. Data are shown as n (%). Abbreviations: ICU, intensive care unit; MV, mechanical ventilation. The results of the multivariable analysis showed that bi-frontal pneumocephalus and endotracheal tube kept at ICU admission (either without or with the need for mechanical ventilation) were independent risk factors for postoperative agitation (). The results of the Hosmer-Lemeshow test showed the model fits the data adequately well (P = 0.782). The Hosmer-Lemeshow test: P = 0.782. Abbreviations: ICU, intensive care unit; MV, mechanical ventilation.

Outcomes

Patients were followed up at a median (IQR) of 10 (8–14) days after the operation. Follow-up data are shown in . Multivariable logistic regression analysis revealed that after adjusting for significant potential confounders, including GCS at ICU admission, endotracheal tube kept at ICU admission, and serum glucose concentration ≥ 10 mmol/L in patients without a history of diabetes, postoperative agitation was independently associated with poor-grade mRS (OR: 5.4, 95% CI: 1.1–28.9, P = 0.048) (). However, after adjusting for significant potential confounders, including GCS at ICU admission, motor function of GCS at ICU admission and endotracheal tube kept at ICU admission, postoperative agitation was not independently associated with longer hospital length of stay (LOS > 10 days) (OR: 1.4, 95% CI: 0.7–2.8, P = 0.294) (). Abbreviations: CVC, central venous catheter; ET, endotracheal tube; ICU, intensive care unit; IQR, interquartile range; MV, mechanical ventilation. Abbreviations: CI, confidential interval; ICU, intensive care unit; GCS, Glasgow Coma Scale. Abbreviations: CI, confidential interval; ICU, intensive care unit; GCS, Glasgow Coma Scale.

Discussion

Our main findings were: 1) early postoperative agitation was prevalent in adult patients who had undergone elective craniotomy for brain tumors and was associated with adverse neurological outcomes; and 2) independent risk factors for agitation included bi-frontal pneumocephalus and delayed extubation, especially with the need for mechanical ventilation. The incidence of agitation in our group of patients (13%) was within the range reported in previous studies (3% to 22%) [1, 3, 5–7, 17–20] but markedly lower than that identified in our previous study (29%) [4]. Several changes to clinical practice in our institution were implemented after the completion of our previous studies. We have incorporated SAS assessment into our daily clinical practice for more than three years [4]. Additionally, according to our previous investigation showing that prophylactic use of dexmedetomidine decreased the incidence of agitation in patients with delayed extubation [10], we routinely initiated continuous dexmedetomidine infusion at low dosage (0.4 μg/kg/h) in mechanically ventilated patients. However, whether these changes in our clinical strategies decreased the rate of agitation requires further investigation. Previous studies found that postoperative delirium, including agitation, was associated with adverse outcomes [21]. We found that postoperative agitation was association with poor-grade mRS even after controlling the potential confounders. The relatively high prevalence of postoperative agitation and its association with adverse neurological outcome indicate the importance of clinical attention to agitated patients who have undergone elective craniotomy. A number of risk factors for postoperative agitation have been reported in non-neurosurgical patients, including premedication, type of anesthesia, delayed extubation and pain [1, 3, 5–7]. In the present study, we found that delayed extubation, especially when occurring in combination with a need for mechanical ventilation, was associated with significantly increased risk of agitation. Although fast track anesthesia has been increasingly used in neurosurgical patients, delayed emergence is still advocated in patients with a high risk of postoperative complications [8, 9, 22, 23]. In our cohort, the prevalence of delayed extubation was 25.5% in patients who had been admitted to the ICU after elective craniotomy, and 40.8% in patients who had undergone infratentorial craniotomy. These data were similar to the results of previous studies [24-29]. Therefore, infratentorial tumors and delayed extubation were the major indications for postoperative ICU management, and clinical staff should be vigilant for the occurrence of agitation in these patients. Pneumocephalus has been found to commonly occur during the early stage after craniotomy, but tension pneumocephalus requiring urgent surgical evacuation occurs rarely [30-34]. In our group of patients, the “Mount Fuji sign” only occurred in 1.0% of study subjects and no emergent operations were performed for intracranial air evacuation, a finding that was in accordance with previous case reports [32]. Appropriate closure of the dura is important for preventing pneumocephalus after craniotomy. The incidence of bi-frontal pneumocephalus (22.5%) in our cohort was lower than previously reported incidence of moderate-to-large pneumocephalus after craniotomy (approximately 50% to 70%) [30, 31]. In our institute, all neurosurgeons received standard pre-job training for intracranial operation, which included the standard procedure for dural closure. However, our results showed that bi-frontal pneumocephalus occurred more frequently in patients undergoing frontal approach (35.8%) and surgery for supratentorial tumor (27.8%), which indeed indicated the margin for further repeatedly reminding and training in dural closure technique. Several case reports have suggested that agitation may occur in some patients with tension pneumocephalus [35, 36]. As expected, bi-frontal pneumocephalus was found to be an independent risk factor for postoperative agitation in our cohort of patients. In the supine position, gas in the subdural space tends to gather in the frontal region. Because the executive function of the frontal lobes involves cognition and emotion [37], stimulating the frontal lobes with a large volume of gas may result in abrupt changes in behavior, including agitation. However, this is only a presumptive mechanism and requires further investigation. Given the preventable nature of large pneumocephalus after elective craniotomy and its relationship with postoperative agitation, several strategies might be adopted into routine clinical practice: 1) neurosurgeons should remain aware of the intricate processes involved with closing the skull, including adequate air removal via physical saline injection before dural closure and prior to carefully suturing the dura; 2) anesthesiologists should use nitrous oxide cautiously, especially during reoperation; and 3) ICU physicians should differentiate between agitation due to pneumocephalus and signs of elevated intracranial pressure. In addition to the use of sedatives and analgesics to control agitation, neurological status should be carefully monitored during the management of agitated patients with pneumocephalus to rule out or confirm the occurrence of tension pneumocephalus. Previous evidence demonstrated that severe intraoperative hyperglycemia was a predictor of higher risk for postoperative infections in patients undergoing craniotomy [38]. In the present study, we determined serum glucose at the ICU admission, which may partly reflect the intraoperative hyperglycemia. We found that hyperglycemia during the early postoperative period, especially in patients without a history of diabetes, occurred more in agitated patients. Our data further enforced the alertness toward hyperglycemia in this population.There are limitations to the present study. First, we only enrolled ICU admitted patients. When compared with those directly returning to the neurosurgical ward, these patients might have had relatively higher ASA classifications, tumors that were more frequently infratentorially located, longer durations of anesthesia and greater amounts of bleeding during surgery. Thus, our patients represented a population that was at high-risk of postoperative agitation, and our results may limit the generalization to the entire population of patients undergoing craniotomy for brain tumors. Second, although we focused on the association between bi-frontal pneumocephalus and agitation, surgical factors potentially associated with pneumocephalus were not collected, such as the opening of the basal cistern and closing of the dura mater. The influence of these factors warrants further investigation. Third, we did not evaluate preoperatively neurological disorders and visual or hearing impairments because it could not be determined in advance which patients would be admitted to the ICU after surgery. Postoperative internal environmental disturbances, such as sleep disorders due to light and noise in the ICU, were not excluded. These factors may also be associated with postoperative agitation in the ICU [39]. Therefore, we cannot rule out a potential bias introduced by these missing data. Fourth, in the present study, we only evaluated postoperative agitation because there is no uniformly accepted tool for assessing delirium in brain injured patients. However, the Confusion Assessment Method (CAM) is increasingly employed in the neurological and neurosurgical patients [40]. Additionally, previous reports have suggested that hypoactive delirium might be more prevalent in the early period following general anesthesia [2, 6]. In the present study, the observation that patients with “Mount Fuji sign” type of pneumocephalus were not agitated might represent the occurrence of hypoactive delirium in this subgroup of patients. Therefore, we are ongoing a study focusing on the postoperative delirium in adult patients after elective intracranial operations to clarify the incidence and risk factors of delirium in this patient population (NCT03087838). In conclusion, we found that early postoperative agitation was frequently identified in patients who had undergone elective craniotomy for brain tumors and was associated with adverse long-term neurological outcome. Risk factors for postoperative agitation included bi-frontal pneumocephalus and delayed extubation and mechanical ventilation. Improvements in the clinical strategies relevant to these risk factors should be considered, and further studies are needed to investigate the effect of such improvements on the occurrence of agitation and clinical outcomes.

STROBE checklist.

(PDF) Click here for additional data file.
Table 1

Univariable analyses of baseline and preoperative data.

VariablesAll patients(n = 400)Agitation(n = 52)Non-agitation(n = 348)P
  Male sex (n [%])169 (42.3)26 (50.0)143 (41.1)0.225
  Age (years; Median [IQR])48 (38–56)51 (36–56)47 (38–56)0.652
  Height (cm; Median [IQR])165 (160–171)168 (160–175)165 (160–170)0.023
  Weight (kg; Median [IQR])66 (60–75)75 (61–83)65 (59–75)0.007
  BMI (kg/m2; Median [IQR])24.4 (22.1–26.7)25.7 (22.4–27.3)24.2 (22.0–26.6)0.064
  ASA classifications (n [%])0.174
    I32 (8.0)5 (9.6)27 (7.8)
    II347 (86.8)43 (82.7)304 (87.4)
    III20 (5.0)3 (5.8)17 (4.9)
    IV1 (0.3)1 (1.9)0 (0.0)
  History of smoking (n [%])41 (10.3)9 (17.3)32 (9.2)0.085
  History of alcohol abuse (n [%])12 (3.0)2 (3.8)10 (2.9)0.660
  History of ADD and/or benzodiazepines (n [%])2 (0.5)1 (1.9)1 (0.3)0.243
  Type of tumor (n [%])0.475
    Gliomas43 (10.8)7 (13.5)36 (10.3)
    Non-gliomas357 (89.3)45 (86.5)312 (89.7)
  Medical history (n [%])108 (27.0%)16 (30.8)92 (26.4)0.512
    History of hypertension87 (21.8)15 (28.8)72 (20.7)0.207
    History of CAD2 (0.5)0 (0)2 (0.6)> 0.999
    History of cardiac arrhythmia7 (1.8)0 (0)7 (2.0)0.602
    History of ischemic stroke5 (1.3)0 (0)5 (1.4)> 0.999
    History of diabetes mellitus25 (6.3)3 (5.8)22 (6.3)> 0.999

Abbreviations: ADD, antidepressant drugs; ASA, American Society of Anesthesiologist; BMI, body mass index; CAD, coronary artery disease; ICU, intensive care unit; IQR, interquartile range.

Table 2

Univariable analyses of intraoperative data.

VariablesAll patients(n = 400)Agitation(n = 52)Non-agitation(n = 348)P
  Frontal approach (n [%])159 (39.8)22 (42.3)137 (39.4)0.686
  Location of the tumor (n [%])0.960
    Supratentorial209 (52.3)27 (51.9)182 (52.3)
    Infratentorial191 (47.6)25 (48.1)166 (47.7)
  Duration of anesthesia (hours; Median [IQR])5.7 (4.7–6.8)6.0 (5.0–7.3)5.7 (4.7–6.7)0.085
  Method of anesthesia (n [%])0.034
    TIVA93 (23.3)6 (11.5)87 (25.0)
    Balanced anesthesia307 (76.7)46 (88.5)261 (75.0)
  Use of opioids for anesthesia maintain (n [%])0.879
    Only remifentanil326 (81.5)43 (82.7)283 (81.3)
    Only sufentanil28 (7.0)4 (7.7)24 (6.9)
    Both remifentanil and sufentanil46 (11.5)5 (9.6)41 (11.8)
  Fluid balance (ml; Median [IQR])1500 (11001988)1650 (1125–2280)1500 (1100–1925)0.258
    Fluid intake (ml; Median [IQR])3500 (2850–4000)3500 (3005–4750)3425 (2750–4000)0.049
    Fluid intake per hour (ml; Median [IQR])600 (509–714)604 (529–747)599 (500–711)0.506
    Fluid output (ml; Median [IQR])1800 (1300–2700)2000 (1300–2900)1775 (1300–2600)0.222
    Fluid output per hour (ml; Median [IQR])324 (240–434)333 (250–421)320 (239–435)0.627
  Amount of bleeding (ml; Median [IQR])300 (200–500)500 (200–1000)300 (200–500)0.005
    Amount of bleeding per hour (ml; Median [IQR])71 (48–113)80 (57–163)70 (48–103)0.018
  Bleed transfusion (n [%])117 (29.3%)23 (44.2%)94 (27.0%)0.011
  Use of mannitol (n [%])147 (36.8%)19 (36.5%)128 (36.8%)0.973
  Use of steroid (n [%])36 (9.0%)4 (7.7%)32 (9.2%)> 0.999
  Episode of hypotension (n [%])137 (34.3%)16 (30.8%)121 (34.8%)0.571

Abbreviations: IQR, interquartile range; TIVA, total intravenous anesthesia.

Table 3

Univariable analyses of ICU admission data.

VariablesAll patients(n = 400)Agitation(n = 52)Non-agitation(n = 348)P
  GCS at ICU admission (Median [IQR])14 (3–14)6 (3–14)14 (4–14)< 0.001
    Motor responses in GCS (Median [IQR])6 (1–6)4 (1–6)6 (2–6)< 0.001
  Body temperature at ICU admission °C (n [%])36.3 (36.0–37.0)36.4 (36.0–37.3)36.3 (36.0–37.0)0.259
    Below 36°C (n [%])69 (17.3)6 (11.5)63 (18.1)0.325
  Endotracheal tube kept (n [%])102 (25.5)28 (53.8)74 (21.3)< 0.001
    Need for mechanical ventilation (n [%])14 (3.5)5 (9.6)9 (2.6)0.025
  CVC (n [%])323 (80.8)44 (84.6)279 (80.2)0.448
  EVD tube (n [%])9 (2.3)2 (3.8)7 (2.0)0.331
  PCIA (n [%])330 (82.5)38 (73.1)292 (83.9)0.055
  SpO2 < 90% (n [%])9 (2.3)0 (0)9 (2.6)0.612
  Serum glucose ≥10mmol/L (n [%])59 (14.8%)12 (23.1)47 (13.5)0.069
    Without diabetes history (n [%])47 (11.8%)11 (21.2)36 (10.3)0.024
  Complaint of pain (n [%])35 (8.8%)9 (17.3)26 (7.5)0.031
First postoperative CT scan (n [%])
    Hematoma18 (4.5)2 (3.8)16 (4.6)>0.999
    Ischemia12 (3.0)2 (3.8)10 (2.9)0.661
    Midline shift26 (6.5)6 (11.5)20 (5.8)0.129
    Bi-frontal pneumocephalus90 (22.5)22 (42.3)68 (19.5)<0.001

Abbreviations: CT, computed tomography; CVC, central venous catheter; EVD, external ventricular drainage; GCS, Glasgow Coma Scale; ICU, intensive care unit; IQR, interquartile range; PCIA, patient-controlled intravenous analgesia; SpO2, pulse oxygenation saturation.

Table 4

Covariate classifications used for in the multivariate model building.

ClassificationsAll patients(n = 400)Agitation(n = 52)Non-agitation(n = 348)P
Hourly bleeding and transfusion0.008
    Minor bleeding197 (49.3)22 (42.3)175 (50.3)
    Major bleeding without transfusion97 (23.5)7 (13.5)90 (25.9)
    Major bleeding with transfusion106 (26.5)23 (44.2)83 (23.8)
Delayed extubation and mechanical ventilation<0.001
    Extubated at operating room298 (74.5)24 (46.2)274 (78.7)
    Endotracheal kept at ICU admission without the need of MV88 (22.0)23 (44.2)65 (18.7)
    Endotracheal kept at ICU admission with the need of MV14 (3.5)5 (9.6)9 (2.6)

Data are shown as n (%).

Abbreviations: ICU, intensive care unit; MV, mechanical ventilation.

Table 5

Independent risk factors for postoperative agitation.

Risk factorsOdd ratio (95% confidential interval)P
Bi-frontal pneumocephalus4.4 (2.2–8.7)< 0.001
Intubation status and mechanical ventilation0.001
    Extubated at operating room1 (reference)
    Endotracheal tube kept at ICU admission without the need of MV3.6 (1.8–7.4)< 0.001
    Endotracheal tube kept at ICU admission with the need of MV5.2 (1.4–19.0)0.014

The Hosmer-Lemeshow test: P = 0.782.

Abbreviations: ICU, intensive care unit; MV, mechanical ventilation.

Table 6

Follow-up data.

VariablesAll patients(n = 400)Agitation(n = 52)Non-agitation(n = 348)
Accident removal of ET and CVC (n [%])3 (0.8)3 (5.8)0 (0)
Duration of MV (hours; median [IQR])11 (5–24) (n = 14)12 (8–24) (n = 5)9 (5–24) (n = 9)
Duration of intubation (hours; median [IQR])16 (16–39) (n = 102)16 (14–22) (n = 28)16 (16–48) (n = 74)
Tracheostomy (n [%])15 (14.7%) (n = 102)4 (14.3%) (n = 28)11 (14.9%) (n = 74)
Re-intubation (n [%])3 (2.9%) (n = 102)1 (3.6%) (n = 28)2 (2.7%) (n = 74)
Use of sedatives (n [%])40 (10.0)33 (63.5)7 (2.0)
    Only dexmedetomidine (n [%])15 (3.8)9 (17.3)6 (1.7)
    Only midazolam (n [%])23 (5.8)22 (42.3)1 (0.3)
    Combined dexmedetomidine and midazolam (n [%])2 (0.5)2 (3.8)0 (0)
Use of fentanyl (n [%])28 (7.0)9 (17.3)19 (5.5)
ICU discharge at postoperative day 1 (n [%])361 (90.3)44 (84.6)317 (91.1)
Unexpected re-operation within 72 hours (n [%])8 (2.0%)1 (1.9%)7 (2.0%)

Abbreviations: CVC, central venous catheter; ET, endotracheal tube; ICU, intensive care unit; IQR, interquartile range; MV, mechanical ventilation.

Table 7

Risk factors for unfavorable functional neurologic outcome (adjusted analysis).

VariablesAdjusted odd ratio (95% CI)P
Agitation5.4 (1.1–28.9)0.048
Serum glucose ≥ 10mmol/L without diabetes history6.2 (1.2–33.1)0.033
GCS at ICU admission1.9 (0.7–5.3)0.231
Endotracheal tube kept at ICU admission0.8 (0.1–5.9)0.858

Abbreviations: CI, confidential interval; ICU, intensive care unit; GCS, Glasgow Coma Scale.

Table 8

Risk factors for longer hospital length of stay (adjusted analysis).

VariablesAdjusted odd ratio (95% CI)P
Agitation1.4 (0.7–2.8)0.294
GCS at ICU admission3.0 (1.6–5.9)0.001
Motor response in GCS at ICU admission1.3 (1.0–1.7)0.056
Endotracheal tube kept at ICU admission1.5 (0.8–2.9)0.189

Abbreviations: CI, confidential interval; ICU, intensive care unit; GCS, Glasgow Coma Scale.

  40 in total

1.  Does propofol anesthesia increase agitation in neurosurgical patients? - a pilot study.

Authors:  Noriaki Kanaya; Hiromitsu Kuroda; Masayasu Nakayama; Yasuyuki Homma; Akiyoshi Namiki
Journal:  Can J Anaesth       Date:  2002 Jun-Jul       Impact factor: 5.063

2.  Emergence delirium in adults in the post-anaesthesia care unit.

Authors:  C Lepousé; C A Lautner; L Liu; P Gomis; A Leon
Journal:  Br J Anaesth       Date:  2006-05-02       Impact factor: 9.166

3.  Modified Rankin Scale and Short-Term Outcome in Cranial Neurosurgery: A Prospective and Unselected Cohort Study.

Authors:  Elina Reponen; Hanna Tuominen; Juha Hernesniemi; Miikka Korja
Journal:  World Neurosurg       Date:  2016-04-07       Impact factor: 2.104

4.  Successful extubation in the operating room after infratentorial craniotomy: the Cleveland Clinic experience.

Authors:  Juan P Cata; Leif Saager; Andrea Kurz; Rafi Avitsian
Journal:  J Neurosurg Anesthesiol       Date:  2011-01       Impact factor: 3.956

Review 5.  Imaging of the post-operative cranium.

Authors:  Audrey G Sinclair; Daniel J Scoffings
Journal:  Radiographics       Date:  2010-03       Impact factor: 5.333

Review 6.  Recovery and neurological evaluation.

Authors:  Neus Fàbregas; Nicolas Bruder
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2007-12

7.  The incidence of pneumocephalus after supratentorial craniotomy. Observations on the disappearance of intracranial air.

Authors:  D K Reasoner; M M Todd; F L Scamman; D S Warner
Journal:  Anesthesiology       Date:  1994-05       Impact factor: 7.892

8.  Pneumocephalus: effects of patient position on the incidence and location of aerocele after posterior fossa and upper cervical cord surgery.

Authors:  T J Toung; R W McPherson; H Ahn; R T Donham; J Alano; D Long
Journal:  Anesth Analg       Date:  1986-01       Impact factor: 5.108

9.  A prospective, comparative trial of three anesthetics for elective supratentorial craniotomy. Propofol/fentanyl, isoflurane/nitrous oxide, and fentanyl/nitrous oxide.

Authors:  M M Todd; D S Warner; M D Sokoll; M A Maktabi; B J Hindman; F L Scamman; J Kirschner
Journal:  Anesthesiology       Date:  1993-06       Impact factor: 7.892

Review 10.  Clinical review: agitation and delirium in the critically ill--significance and management.

Authors:  Jean-Claude Chevrolet; Philippe Jolliet
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  3 in total

1.  Use of the Bispectral Index to Predict Recovery of Consciousness in Patients with Spontaneous Intracerebral Hemorrhage After Surgical Hematoma Evacuation: A Prospective Cohort Study.

Authors:  Yan-Lin Yang; Linlin Zhang; Xuan He; Yi-Min Zhou; Guang-Qiang Chen; Ming Xu; Jian-Xin Zhou
Journal:  Med Sci Monit       Date:  2019-05-09

2.  Dexmedetomidine for the prevention of postoperative delirium in patients after intracranial operation for brain tumours (DEPOD study): a study protocol and statistical plan for a multicentre randomised controlled trial.

Authors:  Xuan He; Kun-Ming Cheng; Linlin Zhang; Hongqiu Gu; Xin Qu; Yuan Xu; Penglin Ma; Jian-Xin Zhou
Journal:  BMJ Open       Date:  2020-11-23       Impact factor: 2.692

3.  Feasibility of low-dose dexmedetomidine for prevention of postoperative delirium after intracranial operations: a pilot randomized controlled trial.

Authors:  Xuan He; Kun-Ming Cheng; Yu-Qing Duan; Shan-Shan Xu; Hao-Ran Gao; Ming-Yue Miao; Hong-Liang Li; Kai Chen; Yan-Lin Yang; Linlin Zhang; Hong-Qiu Gu; Jian-Xin Zhou
Journal:  BMC Neurol       Date:  2021-12-04       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.